-
Press Release
Novartis receives approval for first malaria medicine for newborn babies and young infants
-
Press Release
Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria
-
Story
Sickle cell screening urged for newborns in Africa -
Story
How Emily’s act of bravery inspired a wave of continued innovation -
Press Release
Novartis to initiate SMART Phase 3b global study of Zolgensma in children up to 21 kg, building on real-world experience
-
Press Release
Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis
-
Story
Visionary: Silke Mader has a vision for the care of premature infants and their parents -
Story
Protecting our tomorrows: Portraits of Meningococcal Disease -
Story
Parenting a child with a rare disease -
Story
One boy’s quest to battle cancer -
Story
Creative ways to help kids understand rare diseases -
Story
Fighting respiratory disease at the source